Alignment Healthcare (ALHC) Expected to Announce Earnings on Tuesday

Alignment Healthcare (NASDAQ:ALHC) will likely be posting its quarterly earnings results after the market closes on Tuesday, February 25th. Analysts expect Alignment Healthcare to post earnings of ($0.18) per share and revenue of $675.62 million for the quarter. Parties interested in listening to the company’s conference call can do so using this link.

Alignment Healthcare Stock Down 1.4 %

Shares of NASDAQ ALHC opened at $13.68 on Tuesday. The stock has a market capitalization of $2.62 billion, a price-to-earnings ratio of -17.77 and a beta of 1.50. Alignment Healthcare has a 12-month low of $4.46 and a 12-month high of $15.82. The company has a current ratio of 1.60, a quick ratio of 1.60 and a debt-to-equity ratio of 1.82. The firm’s 50-day moving average price is $13.00 and its 200-day moving average price is $11.67.

Insider Buying and Selling

In other news, insider Andreas P. Wagner sold 14,878 shares of the stock in a transaction on Wednesday, February 12th. The stock was sold at an average price of $14.38, for a total transaction of $213,945.64. Following the transaction, the insider now owns 200,885 shares of the company’s stock, valued at approximately $2,888,726.30. This represents a 6.90 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, COO Sebastian Burzacchi sold 8,550 shares of the company’s stock in a transaction dated Tuesday, December 10th. The stock was sold at an average price of $11.26, for a total transaction of $96,273.00. Following the completion of the sale, the chief operating officer now directly owns 217,395 shares of the company’s stock, valued at approximately $2,447,867.70. This trade represents a 3.78 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 446,002 shares of company stock valued at $5,809,126 in the last 90 days. Company insiders own 6.60% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on ALHC shares. Stephens reaffirmed an “overweight” rating and issued a $17.00 price objective on shares of Alignment Healthcare in a research note on Thursday, January 2nd. Stifel Nicolaus lifted their price objective on shares of Alignment Healthcare from $14.00 to $16.00 and gave the stock a “buy” rating in a research note on Tuesday, January 14th. UBS Group boosted their price objective on shares of Alignment Healthcare from $9.00 to $12.00 and gave the company a “neutral” rating in a research report on Wednesday, October 30th. Finally, Barclays raised their target price on shares of Alignment Healthcare from $7.00 to $8.00 and gave the stock an “underweight” rating in a report on Wednesday, October 30th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, seven have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, Alignment Healthcare has an average rating of “Moderate Buy” and an average price target of $11.88.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.